ESHG: Monday, June 10

Monday, June 10, 2013
08.30 - 10.00	Concurrent Symposia S09 - S12
	S09. New therapeutic highlights in rare diseases S09.1 Adaptive immunodeficiency and gene therapy treatment, Alain Fischer, France S09.2 Antisense therapy in SMA, Adrian Krainer, United States S09.3 Stem-cell gene therapy for the Wiskott-Aldrich Syndrome, Christoph Klein, Germany S10. Reproductive genetics and newborn screening S10.1 Noninvasive whole genome sequencing, Stephen Quake, United States S10.2 New approaches in preimplantation screening, Dagan Wells, United Kingdom S10.3 Newborn screening; what is possible, what do we want?, Bridget Wilcken, Australia S11. Animal Models for Human Diseases S11.1 Mice and Down Syndrome, Yann HÃ©rault, France S11.2 Modelling human diseases in worm, Thorsten Hoppe, Germany S11.3 Modelling human diseases in flies, Bassem Hassan, Belgium S12. Judging our genes S12.1 The geneticist's perspective, Andrew Read, United Kingdom S12.2 Genetics in the courtroom: narrowing down the free-will compass? A social and ethical perspective, Mairi Levitt, United Kingdom S12.3 Narrowing down the free-will compass? A legal perspective, Amedeo Santosuosso, Italy
08.30 - 10.00	Educational Session 6
	ES6. Retinal dystrophies: news and views ES6.1 Inherited retinal dystrophies: insights & challenges behind the rainbow, Frans P. M. Cremers, The Netherlands ES6.2 Inherited retinal disease - management and therapies, Andrew Webster, United Kingdom

10.00 - 10.30	Coffee Break, Free Poster Viewing, Exhibition

10.30 - 11.30	Poster Viewing with Authors (Even poster numbers)

11.30 - 13.15	Free Poster Viewing, Exhibition, Lunch

11.40 - 13.10	Educational Session ES7-ES8
	ES7. NGS in the clinic ES7.1 Introducing next generation technology to clinical scientists, Caroline Wright, United Kingdom ES7.2 Bioinformatic challenges of applying NGS in the clinic, Christian Gilissen, The Netherlands ES8. How to get published in the European Journal of Human Genetics (EJHG) GertJan B. van Ommen, The Netherlands, other speakers to be decided
11.40 - 13.10	Corporate Satellites

13.15 - 14.45	Concurrent Sessions C08 - C14
	C08. Intellectual disability: Gene discovery and dysfunction C09. Population-based sequencing C10. Genetic Counselling, Education and Public Services C11. Molecular mechanisms in tumorigenesis C12. Connective tissue disorders: Gene identification C13. Neurodegenerative disorders: From gene discovery to therapy C14 Sensory disorders and Immunological disorders View details of concurrent sessions

14.45 - 15.15	Vitamin Break, Free Poster Viewing, Exhibition

15.15 - 16.45	Workshops W10 - W14
	Workshop 10: Dysmorphology 2 (Dian Donnai & Jill Clayton-Smith) - View details Workshop 11:Prenatal diagnostic (Milan Macek & Joris Vermeesch) - View details Workshop 12: DNA Dysmorphology (Hans Scheffer, Ove Bruland & BjÃ¸rnIvar Haukanes) - View details Workshop 13: Community genetics (Martina Cornel, Ulf Kristoffersson) - View details Workshop 14: UCSC Genome Browser II (Robert Kuhn) - View details
15.15 - 16.45	Corporate Satellites

16.45 - 17.15	Coffee Break

17.15 - 18.45	Concurrent Symposia S13 - S16
	S13. Stem cells and IPS cells in genetic diseases S13.1 Human pluripotent stem cells for modeling genetic diseases, Oliver Brüstle, Germany S13.2 iPS for modelling diseases and drug screening : the example of Steinertmyotonic dystrophy, CÃ©cile Martinat, France S13.3 IPS cells for targeted gene correction, Ludovic Vallier, United Kingdom S14. Chromosomal (in)stability S14.1 DNA repair and microcephaly, Mark O'Driscoll, United Kingdom S14.2 Consequences of balanced translocations in neurodevelopment, Cynthia Morton, United States S14.3 Chromosomal mosaicisms in aging and cancer, Jan Dumanski, Sweden S15. The interrelated world of drugs and genes S15.1 Drugs and genes - an overview, Ann Daly, United Kingdom S15.2 An immunological basis for pharmacogenetic associations in the MHC, James McCluskey, Australia S15.3 Genetic risk mirrors outcome of anti-TNF therapy in Multiple Sclerosis, Lars Fugger, United Kingdom S16. The expanding world of the primary cilia S16.1 Extreme ciliary phenotypes, Tania Attie, France S16.2 Primary cilia -kidney disease - DNA Repair, Thomas Benzing, Germany S16.3 Moving into and inside cilia: the awesome power of diffusion, Maxence Nachury, United States
17.15 - 18.45	Educational Session 9
	ES9. Where do we come from? ES9.1 A genetics history of our species, Ã‰velyne Heyer, France ES9.2 Tracing back geographic origine and phenotypes using genetic data, Manfred Kayser, The Netherlands
20.00	ESHG Congress Party

To top

Monday, June 10

Monday, June 10, 2013

08.30 - 10.00

Concurrent Symposia S09 - S12

S09. New therapeutic highlights in rare diseases

S10. Reproductive genetics and newborn screening

S11. Animal Models for Human Diseases

S12. Judging our genes

08.30 - 10.00

Educational Session 6

ES6. Retinal dystrophies: news and views

10.30 - 11.30

Poster Viewing with Authors (Even poster numbers)

11.40 - 13.10

Educational Session ES7-ES8

ES7. NGS in the clinic

ES8. How to get published in the European Journal of Human Genetics (EJHG)

11.40 - 13.10

Corporate Satellites

13.15 - 14.45

Concurrent Sessions C08 - C14

C08. Intellectual disability: Gene discovery and dysfunction

C09. Population-based sequencing

C10. Genetic Counselling, Education and Public Services

C11. Molecular mechanisms in tumorigenesis

C12. Connective tissue disorders: Gene identification

C13. Neurodegenerative disorders: From gene discovery to therapy

C14 Sensory disorders and Immunological disorders

15.15 - 16.45

Workshops W10 - W14

15.15 - 16.45

Corporate Satellites

17.15 - 18.45

Concurrent Symposia S13 - S16

S13. Stem cells and IPS cells in genetic diseases

S14. Chromosomal (in)stability

S15. The interrelated world of drugs and genes

S16. The expanding world of the primary cilia

17.15 - 18.45

Educational Session 9

ES9. Where do we come from?

20.00

ESHG Congress Party

ESHG 2013